We efficiently delivered Ldlr mRNA using the proposed strategy to the liver cells, restoring LDLR expression and ameliorating the phenotype of high LDL cholesterol, atherosclerosis, and steatosis in the Ldlr-/- mouse model. Here, LDLR is linked to steatosis.